Spire Wealth Management - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$23,531
+30.5%
616
+23.2%
0.00%0.0%
Q2 2023$18,035
-5.6%
5000.0%0.00%0.0%
Q1 2023$19,095
+63550.0%
500
-4.4%
0.00%
-50.0%
Q4 2022$30
-99.9%
523
-9.7%
0.00%
+100.0%
Q3 2022$23,000
-99.7%
579
-99.6%
0.00%
-99.7%
Q2 2022$7,180,000
+8764.2%
163,186
+8006.6%
0.30%
+14700.0%
Q4 2021$81,000
+3950.0%
2,013
+3200.0%
0.00%
Q3 2021$2,000
-97.6%
61
-97.0%
0.00%
-100.0%
Q1 2021$83,0002,0130.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders